Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

141.19
Delayed Data
As of 3:59pm ET
 -3.92 / -2.70%
Today’s Change
133.64
Today|||52-Week Range
176.85
-13.02%
Year-to-Date
Biotech Stock Roundup: Actelion Remains in M&A Spotlight, ASH Data in Focus
9:32am / Zacks.com - Paid Partner Content
5 Dividend Stocks to Buy in December
Dec 03 / MotleyFool.com - Paid Partner Content
Better Buy: Amgen Inc. vs. Pfizer
8:17am / MotleyFool.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
AbbVie (ABBV) Presents Impressive Imbruvica Data at ASH
Dec 06 / Zacks.com - Paid Partner Content
Here's Why Arrowhead Pharmaceuticals Inc. Is Being Obliterated Today
Nov 30 / MotleyFool.com - Paid Partner Content
Amgen/Allergan File for EU Approval of Avastin Biosimilar
Dec 05 / Zacks.com - Paid Partner Content
Momenta/Shire's Humira Biosimilar Meets Study Objective
Nov 30 / Zacks.com - Paid Partner Content
Acceleron, Celgene Seek to Replace Entrenched Anti-Anemia Drugs in MDS Treatment
Dec 04 / TheStreet.com - Paid Partner Content
Arrowhead Pharma Shares Destroyed by Development Announcement
Nov 30 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close145.11
Today’s open143.52
Day’s range139.66 - 143.88
Volume7,031,300
Average volume (3 months)3,504,825
Market cap$108.0B
Dividend yield2.83%
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+11.34%
Earnings growth (next 5 years)+8.15%
Revenue growth (last year)+6.49%
P/E ratio14.1
Price/Sales5.83
Price/Book3.90

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.31+0.43%
BIIBBiogen-5.86-2.01%
ILMNIllumina Inc-4.38-3.47%
TECHBio-Techne Corp-1.66-1.53%
Data as of 4:14pm ET, 12/07/2016

Financials

Next reporting dateJanuary 31, 2017
EPS forecast (this quarter)$2.80
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts


Search for Jobs